Esperion Therapeutics Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 95.00. In total, the insiders bought 6 546 431 and sold 109 597 ESPR shares in the last 100 trades.

Insider Power

(Last 100 transactions)
95.00
Buy 6 546 431 Shares
Sell 109 597 Shares

Historical Insider Trades

Date Type Action Person Amount
Jun 17, 2025 Common Stock Sell Looker Benjamin 6 422
Jun 17, 2025 Common Stock Sell Koenig Sheldon L. 30 474
Jun 17, 2025 Common Stock Sell Halladay Benjamin 7 229
May 29, 2025 Common Stock Buy Carroll J Martin 33 000
May 29, 2025 Stock Option (right to buy) Buy Carroll J Martin 44 000
May 29, 2025 Common Stock Buy Fischer Seth H. Z. 33 000
May 29, 2025 Stock Option (right to buy) Buy Fischer Seth H. Z. 44 000
May 29, 2025 Stock Option (right to buy) Buy Hoffman Robert E. 7 040
May 29, 2025 Common Stock Buy Hoffman Robert E. 5 280
May 29, 2025 Common Stock Buy Rocamboli Stephen 33 000
May 29, 2025 Stock Option (right to buy) Buy Rocamboli Stephen 44 000
May 29, 2025 Common Stock Buy Shepard Jay 33 000
May 29, 2025 Stock Option (right to buy) Buy Shepard Jay 44 000
May 29, 2025 Stock Option (right to buy) Buy Vitullo Nicole 88 000
May 29, 2025 Stock Option (right to buy) Buy Woody Tracy M 88 000
Apr 17, 2025 Common Stock Sell Warren Eric 108
Apr 17, 2025 Common Stock Sell Halladay Benjamin 8
Apr 01, 2025 Stock Option (right to buy) Buy Hoffman Robert E. 40 000
Apr 01, 2025 Buy Hoffman Robert E. 0
Mar 18, 2025 Common Stock Sell Halladay Benjamin 3 535
Mar 18, 2025 Common Stock Sell Warren Eric 2 433
Mar 18, 2025 Common Stock Sell Koenig Sheldon L. 13 047
Mar 14, 2025 Common Stock Buy Koenig Sheldon L. 840 000
Mar 14, 2025 Stock Option (right to buy Buy Koenig Sheldon L. 753 000
Mar 14, 2025 Common Stock Buy Halladay Benjamin 238 000
Click to get the best stock tips daily for free!
ABOUT ESPERION THERAPEUTICS
Esperion Therapeutics
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascular disease or heterozygous familial hypercholesterolemia. The company has a license and collaboration a...
GOLDEN STAR
Ticker Change Signal Date
G
GTM
$9.57
2.40% Jun 02
TAC
$8.90
23.37% May 12
IMMR
$7.28
4.81% May 09
UAA
$5.84
20.38% May 09
MEDP
$300.81
2.84% May 08

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE